Benzos Schedules of Controlled Substances: Temporary Placement of Etizolam, Flualprazolam, Clonazolam, Flubromazolam, and Diclazepam in Schedule I

[The Shadow Self]

Federal Register :: Request Access

www.federalregister.gov

SUPPLEMENTARY INFORMATION:​

The notice of intent contained in this document is issued pursuant to the temporary scheduling provisions of 21 U.S.C. 811(h). The Drug Enforcement Administration (DEA) intends to issue a temporary scheduling order [1] (in the form of a temporary amendment) to add the following five substances, including their salts, isomers, and salts of isomers, whenever the existence of such salts, isomers, and salts of isomers is possible, to schedule I under the Controlled Substances Act (CSA):

• 4-(2-chlorophenyl)-2-ethyl-9-methyl-6 H -thieno[3,2- f][1,2,4]triazolo[4,3- a][1,4]diazepine (commonly known as etizolam),


• 8-chloro-6-(2-fluorophenyl)-1-methyl-4 H -benzo[ f][1,2,4]triazolo[4,3- a][1,4]diazepine (commonly known as flualprazolam),


• 6-(2-chlorophenyl)-1-methyl-8-nitro-4 H -benzo[ f][1,2,4]triazolo[4,3- a][1,4]diazepine (commonly known as clonazolam),


• 8-bromo-6-(2-fluorophenyl)-1-methyl-4 H -benzo[ f][1,2,4]triazolo[4,3- a][1,4]diazepine (alternate chemical name: 8-bromo-6-(2-fluorophenyl)-1-methyl-4 H -[1,2,4]triazolo[4,3- a][1,4]benzodiazepine and commonly known as, flubromazolam), and


• 7-chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2 H -benzo[ e][1,4]diazepin-2-one (commonly known as diclazepam).

The temporary scheduling order will be published in the Federal Register on or after January 23, 2023.